Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mass spectrometry
Biotech
GV, Sanofi drive preclinical British biotech to $100M series B
VCs pumped $100 million into OMass Therapeutics, teeing the British biotech up to advance candidates against hard-to-hit targets toward the clinic.
Nick Paul Taylor
Apr 28, 2022 2:00am
Charles River Labs deals with SAMDI to boost discovery tech
Jan 28, 2022 12:58pm
MOBILion Systems nets $60M for mass spectrometry tech
Jul 13, 2021 3:10pm
Researchers develop COVID test using atom-thick graphene sheets
Jun 17, 2021 2:05pm
Atonarp nets $50M to chase laser-powered point-of-care tests
May 18, 2021 3:50pm
MOBILion raises $35M to help make mass spec more accurate
Aug 18, 2020 2:10pm
